STAT
JANUARY 11, 2024
In the spring of 2020, Jamal Clay , a gifted young man who grew up in the south suburbs of Chicago, died by suicide. He was 19 years old. Jamal’s loved ones describe him as creative and talented, a leader in different youth-focused organizations in his community who supported and cared for those he loved. He was just as brilliant as he was kind.
PharmaVoice
JANUARY 11, 2024
As advanced therapies and patient perspectives strengthen their foothold in R&D, pharma is poised to deliver impactful treatments in record time.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
STAT
JANUARY 11, 2024
Since having a baby 10 months ago, I’ve learned many things. Chief among them: Pumping sucks. But skipping a session ends up being even more painful. Naturally, I expected navigating the J.P. Morgan Healthcare Conference in San Francisco would be more complicated this year. Somehow, between back-to-back meetings and presentations, I’d have to bust out that abominable contraption and do my thing.
pharmaphorum
JANUARY 11, 2024
Generative AI is revolutionising the pharmaceutical industry, accelerating the speed to market for new drugs. Learn how regulatory processes, R&D, and clinical trials are being impacted by this innovative technology.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
JANUARY 11, 2024
Generative AI’s earliest applications in medicine have largely focused on curing not patients, but the plague of productivity physicians lose to digital documentation. Now, research suggests a way that large language models like ChatGPT could benefit both patients and providers: by automatically extracting a patient’s social needs from reams of text in their clinical records.
pharmaphorum
JANUARY 11, 2024
The FDA is overseeing significant changes in R&D IT as it shifts towards advanced modalities and biologics. This includes the emergence of CRISPR-Cas9 gene editing technology and its potential impact on diseases like sickle cell anaemia. Learn more about these exciting developments in this article.
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
Putting Patients First Blog
JANUARY 11, 2024
New NHC Project Looking at Chronic Kidney Disease Disparities January 11, 2024 By: Lillian Q. Witting, MPH, CAMP, NHC Coordinator, Research, Education & Programs With the start of the new year, the National Health Council (NHC) will be partnering with the American Kidney Fund (AKF) to comprehensively capture the patient experience of those living with chronic kidney disease (CKD), utilizing its evidence-based Patient Experience Mapping toolbox (PEMT).
STAT
JANUARY 11, 2024
My daughter Katie was born with severe disabilities. She went on to develop profound autism, attention deficit disorder, and obsessive-compulsive disorder. The hardest part for her is knowing that she’s different but not understanding how or why. My career as a health care manager and now a researcher has been derailed and fragmented because I have a profoundly disabled daughter who has undergone so many treatments and required special schools.
The Pharmacist
JANUARY 11, 2024
Community pharmacy IT systems will automatically send details of patient consultations to general practice clinical IT systems from February 2024 to facilitate the Pharmacy First service in England, NHS England (NHSE) has confirmed today. A GP will then check and update the patient’s record – replacing the current need for general practice staff to transcribe […] The post Pharmacy IT systems to automatically update GPs from February appeared first on The Pharmacist.
STAT
JANUARY 11, 2024
SAN FRANCISCO — It seemed like there was a point during last year’s J.P. Morgan Healthcare Conference when we all collectively realized, “Oh, 2023 is going to be another slog.” Indeed, a downturn has weighed on the biotech industry for nearly three years. But this January, things feel different. Maybe it’s the abundance of sunlight that filled San Francisco this week.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
European Pharmaceutical Review
JANUARY 11, 2024
Quotient Sciences leverage more than 30 years of drug development expertise to support small molecule and synthetic peptide drug programmes, in both simple drug programmes as well as complex cases where specialised formulation expertise and technologies are required. All drug development programmes are challenging, with numerous stages that an active, lead molecule or new chemical entity (NCE) must transition through to gain regulatory approval and demonstrate its benefits to patients Find out m
STAT
JANUARY 11, 2024
Rune Labs, maker of an Apple Watch app that can track symptoms related to Parkinson’s disease, announced Thursday $12 million in funding led by Nexus NeuroTech, a new venture capital fund focused on brain disorders. Rune in 2021 received Food and Drug Administration clearance for StrivePD, an Apple Watch app that uses the device’s sensors to track two Parkinson’s-related symptoms: tremors and dyskinesia, or the involuntary movements that are a side effect of medication.
European Pharmaceutical Review
JANUARY 11, 2024
The European Commission (EC) has granted a marketing authorisation for Uzpruvo ® (AVT04) in Europe, a biosimilar candidate to Stelara ® (ustekinumab). Ustekinumab biologic Once the European Supplementary Protection Certificate (SPC) for Stelara expires in July 2024, this will open up market entry as soon as possible for Uzpruvo, now that it is approved in Europe” Ustekinumab is a human IgG1κ monoclonal antibody (mAb).
STAT
JANUARY 11, 2024
In honor of JPM Week, you’re reading a special edition of our biotech newsletter, The Readout. To stay on top of the latest scoops and live reporting from the San Francisco conference, join our newsletter list. JPM Week is finally drawing to a close, sending the drug industry’s many financiers scattering from San Francisco to their respective homes and ski destinations.
The Pharmacist
JANUARY 11, 2024
An ITV documentary set to air this evening is hoped to bring home to the general public the struggles faced by community pharmacies. Dr Leyla Hannbeck, chief executive of the Association of Independent Multiple Pharmacies (AIMp), told The Pharmacist that she didn’t think that the general public were fully aware of the extent of the […] The post Hopes for documentary to highlight how ‘pharmacies are going through hell’ appeared first on The Pharmacist.
STAT
JANUARY 11, 2024
The Pashai family of Dallas on Thursday got some good news, but not exactly the news they had spent the last month praying for. The Texas Medicaid program, after denying coverage for an initial consult to begin experimental gene therapy that could save the life of their infant son, Sufyan, now says it will cover the costs for him to be assessed in person by doctors there.
Board Vitals - Pharmacist
JANUARY 11, 2024
January 12th is National Pharmacist Day, when we recognize the contribution that pharmacists have made–and continue to make–to patient care and our healthcare systems. Each year, patients fill hundreds of millions of prescriptions, keeping pharmacists busier than ever. Beyond filling prescriptions, they work to ensure our medications are safe and effective.
STAT
JANUARY 11, 2024
Is biotech back from its downturn? Can Nvidia solve biology? And is it wise to do a deal on a party bus? We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Recording from the J.P. Morgan Healthcare Conference, we discuss how a spate of deals and some intermittent sunshine seem to have brightened the outlook for biotech at the outset of 2024.
Pharma Times
JANUARY 11, 2024
The diagnostic system can deliver particles to the lungs via aerosol or a nebuliser
STAT
JANUARY 11, 2024
You’re reading the web edition of STAT’s Health Tech newsletter, our guide to how technology is transforming the life sciences. Sign up to get it delivered in your inbox every Tuesday and Thursday. Teladoc makes its case for sustained growth Teladoc CEO Jason Gorevic used the JPM 2024 stage to explain why the company believes it’s got plenty of “running room” to grow its integrated care business that connects people to a host of virtual hea
Express Pharma
JANUARY 11, 2024
Since 2017, India has worked on developing its own laws on the right to privacy. The Digital Personal Data Protection Act 2023, India’s version of Europe’s GDPR, gives Indian citizens the right to protect their own data. In August of this year, both the lower and upper houses of the Parliament of India passed the bill. On August 11, the President of India gave assent to the bill, which makes it officially the Digital Personal Data Protection Act, 2023.
STAT
JANUARY 11, 2024
Rise and shine, another busy day is on the way. However, this is also shaping up as a beautiful day as well, given the clear and sunny skies — and unusually mild breezes — enveloping the Pharmalot campus this morning. This calls for celebration with a cup of stimulation, and we are opening a new package of salted caramel mocha for the occasion.
The Pharmacist
JANUARY 11, 2024
A number of grants from Pharmacy Research UK (PRUK) are now open for application, including full funding for a full-time PhD studentship. The PhD Studentship Award is being trialled in PRUK’s annual funding round for the first time in place of its Research Development Awards. It is designed to support the salary, tuition and research […] The post Research grants open for UK pharmacists and pharmacy technicians appeared first on The Pharmacist.
pharmaphorum
JANUARY 11, 2024
Stada and Alvotech get EU approval for first biosimilar of Johnson & Johnson's Stelara in psoriasis, psoriatic arthritis and Crohn's disease indications
Express Pharma
JANUARY 11, 2024
Unichem Laboratories is pleased to announce that it has received ANDA approval for its Doxazosin Tablets USP, 1 mg, 2 mg, 4 mg and 8 mg from the United States Food and Drug Administration (USFDA) to market a generic version of Cardura (Doxazosin) Tablets, 1 mg, 2 mg, 4 mg and 8 mg, of Viatris Specialty, LLC. Doxazosin tablets are indicated for the treatment of hypertension, to lower blood pressure.
pharmaphorum
JANUARY 11, 2024
In this new episode of the pharmaphorum podcast, host Nicole Raleigh speaks with James Burt, CEO of Pharmanovia, about the value-added medicines space.
Pharma Times
JANUARY 11, 2024
In 2022, around 8% of patients survived 30 days after a cardiac arrest
BioPharma Dive
JANUARY 11, 2024
Investors and executives interviewed by BioPharma Dive at J.P. Morgan say new companies have to be leaner, hire more conservatively and focus on their first medicines quickly.
EMCrit Project
JANUARY 11, 2024
Should DSI become the new standard? EMCrit Project by Scott Weingart, MD FCCM.
pharmaphorum
JANUARY 11, 2024
NICE has extended the NHS availability of Pfizer’s COVID-19 drug Paxlovid as millions of doses approach their expiry date
Express Pharma
JANUARY 11, 2024
The sales growth of gout therapies across the seven major markets (7MM: the US, 5EU, and Japan) is set to increase at a compound annual growth rate (CAGR) of 8.8 per cent from $4.6 billion in 2022 to $10.8 billion in 2032, in line with the steadily increasing disease prevalence and the entrance of novel agents, according to GlobalData. GlobalData’s latest report, “Gout Market Opportunity Assessment, Epidemiology, Clinical Trials, Unmet Needs and Forecast to 2032,” reveals that there are nine the
Welltopia Pharmacy
JANUARY 11, 2024
The Comprehensive Guide to Weight Loss with Low Dose Naltrexone Low Dose Naltrexone (LDN) is medically known for its substantial
pharmaphorum
JANUARY 11, 2024
CHMP has called in expert advisors to assist in the review of Eisai and Biogen’s Alzheimer's therapy Leqembi
European Pharmaceutical Review
JANUARY 11, 2024
chronic neuropathic pain is at present, mainly managed with antidepressants… antiepileptic drugs… as well as opioids” Neuropathic pain affects over 400 million people worldwide, according to Hoba Therapeutics. In Europe, the prevalence of chronic neuropathic pain is estimated to be six–eight percent 1 of the general population. Drug development for pain management is “incredibly complex… mainly because the trials are so challenging to conduct”, the company highlight
pharmaphorum
JANUARY 11, 2024
FDA has authorised imports from France of a life-saving antibiotic for syphilis that is in short supply in the domestic market
Expert insights. Personalized for you.
363 
Let's personalize your content